You have 9 free searches left this month | for more free features.

Pemphigus

Showing 26 - 50 of 129

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pemphigus Vulgaris Trial in Worldwide (Mycophenolate Mofetil Placebo, Mycophenolate Mofetil, Rituximab)

Completed
  • Pemphigus Vulgaris
  • Mycophenolate Mofetil Placebo
  • +3 more
  • Birmingham, Alabama
  • +67 more
Oct 16, 2020

Periodontal Status in Patients With Chronic Skin Diseases

Completed
  • Periodontal Diseases
  • +4 more
  • oral health status
  • Ho Chi Minh City, Vietnam
    University of Medicine and Pharmacy at Ho Chi Minh city
Oct 5, 2023

Autoimmune Bullous Dermatose Trial in Bordeaux, Paris, Rouen (Cellcept® in autoimmune bullous dermatoses)

Completed
  • Autoimmune Bullous Dermatose
  • Cellcept® in autoimmune bullous dermatoses
  • Bordeaux, France
  • +2 more
Apr 19, 2019

Prevelance Of Cutaneous Disorders Among Heamatologic

Not yet recruiting
  • Dermatologic Disorders With Heamatologic Malignancies Patients
  • cbc ,u\s renalor hepatic function test if needed
  • Sohag, Egypt
    Sohag university Hospital
Oct 25, 2023

Pemphigus Vulgaris Trial in Worldwide (Ofatumumab, Placebo)

Terminated
  • Pemphigus Vulgaris
  • Ofatumumab
  • Placebo
  • Los Angeles, California
  • +15 more
May 14, 2019

Bullous Dermatoses, Psoriasis, COVID-19 Vaccines Trial in Ratchathewi (tozinameran)

Recruiting
  • Bullous Dermatoses
  • +2 more
  • tozinameran
  • Ratchathewi, Bangkok, Thailand
    Dermatology outpatient clinic, Somdech Phra Debaratana Medical C
Aug 22, 2022

Autoimmune Diseases Trial (Rituximab, corticosteroids'therapy)

Unknown status
  • Autoimmune Diseases
  • (no location specified)
Dec 27, 2018

Routine Health Insurance Data With Focus on Autoimmune Diseases

Active, not recruiting
  • Virus Diseases
  • Exposed to a SARS-CoV-2 infection
  • Dresden, Saxony, Germany
    Center for Evidence-Based Healthcare, Technische Universität Dre
Jan 25, 2023

Tissue-resident Memory T Cells Expression in Melasma

Completed
  • Melasma
    • San Luis Potosí, Mexico
      Dermatology Department. Hospital Central "Dr. Ignacio Morones Pr
    Jan 15, 2023

    Autoimmune Diseases Trial in Shenzhen, Guilin (4SCAR T cells)

    Recruiting
    • Autoimmune Diseases
    • 4SCAR T cells
    • Shenzhen, Guangdong, China
    • +1 more
    Jul 17, 2022

    Bullous Pemphigoid Trial in Germany, Italy (DF2156A)

    Terminated
    • Bullous Pemphigoid
    • Freiburg, Germany
    • +3 more
    Jan 14, 2022

    Hailey Hailey Disease Trial in Maastricht (Skin biopsy)

    Unknown status
    • Hailey Hailey Disease
    • Skin biopsy
    • Maastricht, Limburg, Netherlands
      Maastricht University Medical Center
    Feb 20, 2019

    Diabetes type1 Trial (cePolytreg)

    Not yet recruiting
    • Diabetes type1
    • cePolytreg
    • (no location specified)
    Jul 8, 2022

    Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial

    Recruiting
    • Relapsing Remitting Multiple Sclerosis
    • +2 more
    • Glostrup, Copenhagen, Denmark
    • +11 more
    May 3, 2022

    Autoimmune Bullous Disease Trial in Seoul (Biopsy)

    Recruiting
    • Autoimmune Bullous Disease
    • Biopsy
    • Seoul, Korea, Republic of
      GangnamSeverance Hospital
    Mar 14, 2022

    Subarachnoid Hemorrhage, Brain Ischemia, Subarachnoid Hemorrhage, Aneurysmal Trial in Mexico City (Dapsone, Aluminum Hydroxide

    Completed
    • Subarachnoid Hemorrhage
    • +5 more
    • Mexico City, Mexico
      El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasc
    Nov 10, 2021

    "Abnormality", Including Non ST Elevation Myocardial Infarction,

    Completed
    • Myocardial Infarction
      • Southampton, United Kingdom
        Southampton General Hospital
      Dec 9, 2020

      Proteasomes inDermatological Autoimmune Disease: Bullous

      Terminated
      • Pemphigoid, Bullous
      • +2 more
        • Nîmes Cedex 09, France
          CHU de Nîmes - Hôpital Universitaire Carémeau
        May 4, 2018

        Idiopathic Thrombocytopenic Purpura, Thrombocytopenia, Thrombocytopenic Purpura Trial (Romiplostim)

        Completed
        • Idiopathic Thrombocytopenic Purpura
        • +2 more
        • Romiplostim
        • (no location specified)
        Nov 10, 2022

        Oral Mucositis Using Platelet Rich Fibrin TREATMENT OF ORAL

        Completed
        • Graft Vs Host Disease
        • +2 more
        • TREATMENT OF ORAL MUCOSITIS USING PLATELET-RICH-FIBRIN (PRF)
        • Taviano, Italy
          Francesco Gianfreda
        Aug 18, 2021

        Oral Ulcer Due to Pemphius Vularis, Oral Ulcer Due to Benign Mucous Membrane Pemphioid, Oral Ulcer Due to Steven Johnson's

        Completed
        • Oral Ulcer Due to Pemphius Vularis
        • +2 more
        • Platelet rich fibrin gel in Orabase
        • Dermovate cream in Orabase
        • Beni-Suef, Beni Suef, Egypt
          Eman Ahmed
        Sep 3, 2020

        Lingual Microcystic Lymphatic Malformations Trial in Tours, Orléans, Paris (Sirolimus Oral Liquid Product 1mg/mL)

        Recruiting
        • Lingual Microcystic Lymphatic Malformations
        • Sirolimus Oral Liquid Product 1mg/mL
        • Tours, Indre Et Loire, France
        • +2 more
        Mar 3, 2022

        Pemphigus Trial in United States (Infliximab, Placebo Comparator)

        Completed
        • Pemphigus
        • Los Angeles, California
        • +3 more
        Nov 1, 2017

        Chronic Lymphocytic Leukemia Trial in Worldwide (Venetoclax)

        Completed
        • Chronic Lymphocytic Leukemia
        • Louisville, Kentucky
        • +66 more
        Nov 9, 2022

        Lung Cancer Trial in Worldwide (Nivolumab, Topotecan, Amrubicin)

        Active, not recruiting
        • Lung Cancer
        • Little Rock, Arkansas
        • +149 more
        Apr 7, 2022